Latuda FDA Approval History
FDA Approved: Yes (First approved October 28, 2010)
Brand name: Latuda
Generic name: lurasidone
Dosage form: Tablets
Company: Dainippon Sumitomo Pharma America, Inc.
Treatment for: Schizophrenia, Bipolar Disorder
Latuda (lurasidone) is an atypical antipsychotic agent for the treatment of schizophrenia and bipolar depression.
Development Timeline for Latuda
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.